Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC

Background: Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease. Crone's disease (CD) and ulcerative colitis (UC) are types of IBD. There is a need for a more accurate, noninvasive biomarker to distinguish CD from UC. Purpose: To verify the diagnostic value of combined serum trypsin 2 (PRSS2) and serum amyloid P component (SAP) evaluation in distinguishing CD from UC. Methods: The subjects included 28 normal controls (NC) as well as 44 UC, 72CD, 16 colorectal cancer (CRC), 10 colorectal polyps, and 10 cancer cases. Serum SAP, PRSS2, CRP, and CEA were measured and compared. Results: The concentration of CEA in CRC and other gastrointestinal tumors was significantly higher than that in UC, CD, and colorectal polyps. The concentration of CRP was significantly higher in UC and CD than that in the healthy group, but there were no significant differences when compared to the intestinal polyp group. Serum PRSS2 concentration was significantly higher in the UC and CD groups than that in the colorectal polyp group, and the average serum concentration of SAP in CD was significantly higher compared to UC. In patients with colorectal polyps, there was no correlation between PRSS2 and CRP. ROC curve analysis showed that the AUC of PRSS2 used to distinguish IBD patients from healthy controls or colorectal polyp patients was 0.730 and 0.774, respectively. The AUC of SAP used to distinguish CD from UC was 0.706. The AUC of combined PRSS2 and SAP was not different from the AUC for individual SAP. Finally, we demonstrated that the expression of SAP in CD patient tissues was significantly higher than that in UC patients. Conclusion: The combined analysis of serum SAP and PRSS2 has differential diagnostic value for CD and UC.

Automated summary

The combined analysis of serum SAP and PRSS2 has differential diagnostic value for CD and UC. CEA, CRP, and other indicators can also help distinguish different diseases. ROC curve analysis shows that PRSS2 has a certain diagnostic effect in distinguishing intestinal inflammation patients, while SAP is better for distinguishing CD and UC.